Abstract
Breast cancer is the most common cancer, and the second most common cause of cancer-related death in females (Fig. 7.1). It is an important cause of morbidity and mortality despite recent developments in early diagnosis and treatment. Early diagnosis is common in developed countries due to regular screening programs [1].
Keywords
- Breast Cancer
- Axillary Lymph Node
- Axillary Dissection
- Ipsilateral Breast Tumor Recurrence
- Modify Radical Mastectomy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Cancer Society (2007) American Cancer Society: Cancer facts and figures 2007. American Cancer Society, Atlanta, GA
AJCC (2010) Breast. In: Edge SB, et al. American Joint Committee on Cancer: AJCC cancer staging manual, 6th edn. Springer, New York, NY, pp 347–367
Yeatman TJ, Cantor AB, Smith TJ et al (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222 (4):549–559; discussion 559–561
Roddy HJ, Silverberg SG (1980) Ultrastructural analysis of apocrine carcinoma of the human breast. Ultrastruct Pathol 1:385–393
Adler OB, Engel A (1990) Invasive lobular carcinoma. Mammographic pattern. Rofo 152(4):460–462
Ackland SP, Bitran JD, Dowlatshahi K (1985) Management of locally advanced and inflammatory carcinoma of the breast. Surg Gynecol Obstet 161(4):399–408 (review)
Valenzuela M, Julian TB (2007) Ductal carcinoma in situ: biology, diagnosis, and new therapies. Clin Breast Cancer 7(9):676–681 (review)
Hanby AM, Hughes TA (2008) In situ and invasive lobular neoplasia of the breast. Histopathology 52(1):58–66 (review)
Hansen EK, Mack Roach III (2006) Handbook of evidence-based radiation oncology. Springer, New York, pp 189–191
Lee MC, Jagsi R (2007) Postmastectomy radiation therapy: indications and controversies. Surg Clin North Am 87(2):511–526; xi (review)
Pritchard KI, Shepherd LE, O’Malley FP et al (2006) HER2 and responsiveness of breast cancer to adjuvant chemotherapy. N Engl J Med 354(20):2103–2111
Ueno NT, Buzdar AU, Singletary SE et al (1997) Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center. Cancer Chemother Pharmacol 40(4):321–329
Weiss MC, Fowble BL, Solin LJ et al (1992) Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys 23(5):941–947
Feller WF, Holt R, Spear S et al (1986) Modified radical mastectomy with immediate breast reconstruction. Am Surg 52(3):129–133
Whelan T, MacKenzie R, Julian J et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94(15):1143–1150
Owen JR, Ashton A, Bliss JM et al (2006) Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7(6):467–471
Vicini FA, Sharpe M, Kestin L et al (2002) Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 54:1336–1344
Jatoi I, Kaufmann M, Petit JY (2006) Atlas of breast surgery. Springer, New York
Greene FL, Page DL, Fleming ID et al (2002) American Joint Committee on Cancer. AJCC cancer staging manual, 6th edn. Springer, New York
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ozyigit, G., Beyzadeoglu, M., Ebruli, C. (2010). Breast Cancer. In: Basic Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11666-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-11666-7_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11665-0
Online ISBN: 978-3-642-11666-7
eBook Packages: MedicineMedicine (R0)